Atrin Pharmaceuticals' Unattributed - II Round

Atrin Pharmaceuticals raised a round of funding on April 01, 2016.

Atrin Pharmaceuticals is a dynamic biopharmaceutical firm focused on the discovery and development of proprietary medications. Atrin centers its research on modalities which treat cancers lacking effe…

Articles about Atrin Pharmaceuticals' Unattributed - II Round: